pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-0.43%	-1.26%	+52.13%	+85.69%	5.56TCr
ARGENX SE	-0.24%	+1.04%	+55.76%	+58.36%	5.43TCr
BIONTECH SE	-0.60%	-0.11%	-17.54%	-14.15%	2.33TCr
INSMED INCORPORATED	-1.89%	-3.03%	+3.46%	+420.45%	2.35TCr
WUXI BIOLOGICS (CAYMAN) INC.	+0.05%	+1.68%	+38.71%	-4.57%	2.03TCr
GENMAB A/S	+3.16%	+0.79%	+37.98%	-29.06%	1.74TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+1.08%	+3.77%	+36.92%	+593.96%	1.56TCr
PHARMAESSENTIA CORPORATION	+0.43%	-1.67%	+166.53%	+299.61%	1.5TCr
EXELIXIS, INC.	-1.54%	-0.36%	+24.47%	+178.28%	1.41TCr
Average	-0.08%	-0.23%	+44.27%	+176.51%	2.66TCr
Weighted average by Cap.	-0.16%	-0.23%	+43.72%	+138.70%